HGS1029 (AEG40826-2HCl)

AEG40826-2HCl · Human Genome Sciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HGS1029 (AEG40826-2HCl), covering 2013-11-07 to 2013-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors [Phase 1]